BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 33926416)

  • 1. Altered expression profile of BAFF receptors on peripheral blood B lymphocytes in Graves' disease.
    Wang X; Huang J; Zhang A; Fang C; Ma Q; Jiang P
    BMC Endocr Disord; 2021 Apr; 21(1):88. PubMed ID: 33926416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B Cell Activating Factor (BAFF) and BAFF Receptor Expression in Autoimmune and Nonautoimmune Thyroid Diseases.
    Campi I; Tosi D; Rossi S; Vannucchi G; Covelli D; Colombo F; Trombetta E; Porretti L; Vicentini L; Cantoni G; Currò N; Beck-Peccoz P; Bulfamante G; Salvi M
    Thyroid; 2015 Sep; 25(9):1043-9. PubMed ID: 26214745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synchronized expressions of serum osteopontin and B cell-activating factor in autoimmune thyroid disease.
    Cheng CW; Tang KT; Fang WF; Lin JD
    Eur J Clin Invest; 2019 Jul; 49(7):e13122. PubMed ID: 31034586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 25-Hydroxyvitamin D serum level in Hashimoto's thyroiditis, but not Graves' disease is relatively deficient.
    Ke W; Sun T; Zhang Y; He L; Wu Q; Liu J; Zha B
    Endocr J; 2017 Jun; 64(6):581-587. PubMed ID: 28413173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum BAFF concentrations in patients with Graves' disease and orbitopathy before and after immunosuppressive therapy.
    Vannucchi G; Covelli D; Currò N; Dazzi D; Maffini A; Campi I; Bonara P; Guastella C; Pignataro L; Ratiglia R; Beck-Peccoz P; Salvi M
    J Clin Endocrinol Metab; 2012 May; 97(5):E755-9. PubMed ID: 22399512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves' disease and Graves' orbitopathy.
    Marinò M; Rotondo Dottore G; Ionni I; Lanzolla G; Sabini E; Ricci D; Sframeli A; Mazzi B; Menconi F; Latrofa F; Vitti P; Marcocci C; Chiovato L
    J Endocrinol Invest; 2019 Apr; 42(4):471-480. PubMed ID: 30132285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Participation of B-cell-activating factor receptors in the pathogenesis of immune thrombocytopenia.
    Min YN; Wang CY; Li XX; Hou Y; Qiu JH; Ma J; Shao LL; Zhang X; Wang YW; Peng J; Hou M; Shi Y
    J Thromb Haemost; 2016 Mar; 14(3):559-71. PubMed ID: 26749059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous measurement of twenty-nine circulating cytokines and growth factors in female patients with overt autoimmune thyroid diseases.
    Cheng CW; Wu CZ; Tang KT; Fang WF; Lin JD
    Autoimmunity; 2020 Aug; 53(5):261-269. PubMed ID: 32338082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
    Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
    Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased nerve growth factor levels in hyperthyroid Graves' ophthalmopathy highlighting the role of neuroprotective factor in autoimmune thyroid diseases.
    Molnár I; Bokk A
    Cytokine; 2006 Aug; 35(3-4):109-14. PubMed ID: 17008110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expressions of BAFF/BAFF receptors and their correlation with disease activity in Chinese SLE patients.
    Zhao LD; Li Y; Smith MF; Wang JS; Zhang W; Tang FL; Tian XP; Wang HY; Zhang FC; Ba DN; He W; Zhang X
    Lupus; 2010 Nov; 19(13):1534-49. PubMed ID: 20974656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.
    Yin X; Latif R; Bahn R; Tomer Y; Davies TF
    Thyroid; 2008 Nov; 18(11):1201-6. PubMed ID: 18925838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of Fas system apoptotic molecules in peripheral lymphocytes from patients with Graves' disease and Hashimoto's thyroiditis.
    Fountoulakis S; Vartholomatos G; Kolaitis N; Frillingos S; Philippou G; Tsatsoulis A
    Eur J Endocrinol; 2008 Jun; 158(6):853-9. PubMed ID: 18505906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low serum interleukin-38 levels in patients with Graves' disease and Hashimoto's thyroiditis.
    Xu J; Huang G; Weng L; Gong L; Mao Y; Li Y; Li M
    J Clin Lab Anal; 2022 Jan; 36(1):e24101. PubMed ID: 34799942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different levels of circulating Th22 cell and its related molecules in Graves' disease and Hashimoto's thyroiditis.
    Song RH; Yu ZY; Qin Q; Wang X; Muhali FS; Shi LF; Jiang WJ; Xiao L; Li DF; Zhang JA
    Int J Clin Exp Pathol; 2014; 7(7):4024-31. PubMed ID: 25120780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum CD40/CD40L system in Graves' disease and Hashimoto's thyroiditis related to soluble Fas, FasL and humoral markers of autoimmune response.
    Mysliwiec J; Oklota M; Nikolajuk A; Waligorski D; Gorska M
    Immunol Invest; 2007; 36(3):247-57. PubMed ID: 17558708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of CD4+CD161+CD196+ and CD4+IL-17+ Th17 cells in the peripheral blood of young patients with Hashimoto's thyroiditis and Graves' disease].
    Bossowski A; Moniuszko M; Idźkowska E; Dąbrowska M; Jeznach M; Sawicka B; Borysewicz-Sańczyk H; Bossowska A; Rusak M; Bodzenta-Łukaszyk A
    Pediatr Endocrinol Diabetes Metab; 2012; 18(3):89-95. PubMed ID: 23146786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum BAFF and thyroid autoantibodies in autoimmune thyroid disease.
    Lin JD; Wang YH; Fang WF; Hsiao CJ; Chagnaadorj A; Lin YF; Tang KT; Cheng CW
    Clin Chim Acta; 2016 Nov; 462():96-102. PubMed ID: 27616625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum selenium and selenoprotein-P levels in autoimmune thyroid diseases patients in a select center: a transversal study.
    Federige MAF; Romaldini JH; Miklos ABPP; Koike MK; Takei K; Portes ES
    Arch Endocrinol Metab; 2017 Dec; 61(6):600-607. PubMed ID: 29412385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clustering of additional autoimmunity behaves differently in Hashimoto's patients compared with Graves' patients.
    Wiebolt J; Achterbergh R; den Boer A; van der Leij S; Marsch E; Suelmann B; de Vries R; van Haeften TW
    Eur J Endocrinol; 2011 May; 164(5):789-94. PubMed ID: 21378091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.